ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹6,229 Cr |
Mar2023 | ₹5,653 Cr |
Mar2022 | ₹5,306 Cr |
Mar2021 | ₹5,393 Cr |
Mar2020 | ₹4,606 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹6,229 Cr | 10.19 | |
Mar2023 | ₹5,653 Cr | 6.54 | |
Mar2022 | ₹5,306 Cr | -1.62 | |
Mar2021 | ₹5,393 Cr | 17.10 | |
Mar2020 | ₹4,606 Cr | - |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹19,212.7 Cr | -7.2% | -5.7% | 8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -7.2% |
-5.7% |
8.1% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses